Filter
3560
Filtered Results: 3560
Text search:
Center
for
Disease
control
and
prevention
Featured
Recommendations
316
New Publications
905
Language
Document type
No document type
2006
Studies & Reports
608
Guidelines
467
Manuals
182
Strategic & Response Plan
99
Fact sheets
76
Training Material
54
Situation Updates
39
Infographics
10
Resource Platforms
9
Online Courses
5
Brochures
3
App
1
Videos
1
Countries / Regions
India
172
Global
125
Ethiopia
105
Liberia
92
Kenya
81
Rwanda
78
Nepal
74
Latin America and the Carribbean
70
Sierra Leone
65
Africa
62
Nigeria
57
Uganda
52
Philippines
51
Western and Central Europe
51
Malawi
46
Bangladesh
43
Tanzania
40
Zambia
37
Ukraine
36
Myanmar / Burma
36
Mozambique
35
Haiti
34
Russia
33
Congo, Democratic Republic of
30
Syria
29
Cambodia
29
Brazil
29
Eastern Europe
28
Senegal
27
Guinea
26
Ghana
26
Indonesia
26
Asia
25
South Africa
23
South Sudan
20
Namibia
20
Lesotho
20
Burkina Faso
18
Zimbabwe
18
South–East Asia Region
17
Germany
16
Yemen
16
USA
15
Middle East and North Africa
15
Angola
14
West and Central Africa
14
Colombia
13
Eastern Europe and Central Asia
13
East and Southern Africa
11
Cameroon
10
Thailand
10
Argentina
9
Botswana
9
Venezuela
9
Albania
9
Guinea-Bissau
7
Pakistan
7
Afghanistan
7
Ecuador
7
Western Pacific Region
7
Georgia
7
Vietnam
7
China
6
Central African Republic
6
Eswatini/ Swaziland
6
Paraguay
6
Armenia
6
Mali
5
Jordan
5
Benin
5
Peru
5
Chile
5
Laos
5
Tajikistan
5
Moldova
5
Somalia
4
Madagascar
4
Sri Lanka
4
North America
4
Japan
4
Côte d’Ivoire / Ivory Coast
3
North Macedonia
3
Burundi
3
El Salvador
3
Bolivia
3
Mexico
3
Palestine
3
Kazakhstan
3
France
3
United Kingdom
3
Portugal
3
Spain
3
Belarus
3
Saudi Arabia
2
Iraq
2
Lebanon
2
Turkey
2
Chad
2
Malaysia
2
Honduras
2
Libya
2
Bhutan
2
Canada
2
Timor Leste/ East Timor
2
Romania
2
Gabon
2
Jamaica
2
Niger
1
Egypt
1
Papua New Guinea
1
Sudan
1
Austria
1
Switzerland
1
Hungary
1
Greece
1
Other region
1
Poland
1
Italy
1
Southern Africa
1
Qatar
1
Estonia
1
Lithuania
1
Iran
1
Kyrgyzstan
1
Turkmenistan
1
Belgium
1
Mauritius
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
1320
Clinical Guidelines
286
Public Health
205
Women & Child Health
145
Key Resources
135
Capacity Building
63
Pharmacy & Technologies
39
Toolboxes
COVID-19
375
HIV
306
Mental Health
255
TB
219
AMR
159
Ebola
137
Planetary Health
115
Rapid Response
114
NTDs
111
Caregiver
84
NCDs
77
Conflict
58
Global Health Education
58
Disability
55
Refugee
52
Pharmacy
50
Zika
49
Natural Hazards
44
Cholera
38
Health Financing Toolbox
33
Specific Hazards
23
Polio
15
Social Ethics
4
Typhoon
2
Health Financing
2
South Sudan
1
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention ... control programme. The guidance includes a step-by-step process to be followed after the decision has been made to specifically introduce and/or scale-up HPV virological testing for screening, which would be followed up with adequate management within the context of cervical cancer prevention
Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft ... prevention of disability are needed in some cases to ensure full recovery.
The target set by the World Health Organization (WHO) for control of Buruli ulcer is for countries to achieve a rate of case confirmation by PCR of at least 70%. All endemic countries have at least one PCR facility to support confirmation of cases. However, most countries in the WHO African Region have not been able to reach the target, and the rate of case confirmation has been declining
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce ... combine with wider initiatives, such as those aimed at strengthening primary health care and health systems, increasing immunization coverage, improving global health security, fighting antimicrobial resistance and advocating for the rights of persons with disabilities. It will complement other global control strategies, such as those addressing sepsis, pneumonia, tuberculosis and HIV. Implementation will be a challenge for all countries across the world, but especially in resource-poor settings where the burden of meningitis is greatest. The targets for the visionary and strategic goals will be adapted to regional and local contexts.
This report has been developed, based on data provided by the TB & ORD surveillance system from across Rwanda. It provides a comprehensive picture of the occurrence and management of TB & ORD and Le...
For humanitarian organisations to respond effectively to complex crises, they require access to up-to-date evidence-based guidance. The COVID-19 crisis has highlighted the importance of updating global guidance to context-specific ... evolving needs in humanitarian settings. Our study aimed to understand the use of evidence-based guidance in humanitarian responses during COVID-19. Primary data collected during the rapidly evolving pandemic sheds new light on evidence-use processes in humanitarian response.
The Government of India is embarking on a mammoth task to prevent COVID-19 spread among communities. The Rapid Evidence Synthesis team received a request to support the planning and development of resources ... ensuring preparedness of FLHWs for COVID-19 . The rapid evidence synthesis was conducted in a period of three days.
The findings highlight what we can learn from recent pandemics such that we are prepared for potential scenarios and challenges due to COVID-19. Key issues which decision-makers need to consider, based on available evidence
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improv...
Best Practices Report.PART 1 Primary Protection: Enhancing Health Care Resilience for a Changing Climatei Primary Protection: EnhancingU.S. Department of Health and Human Services
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, an... less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The hematophagous triatomine vectors defecate during or immediately after feeding on a person. The parasite is present in large numbers in the feces of infected bugs, and enters the human body through the bite wound, or through the intact conjunctiva or other mucous membrane.
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. ...
Environmental pollution, protection, quality and sustainability
As information about COVID-19 is rapidly evolving, it can be challenging to navigate and synthesize all of the information. The purpose of this document is to provide a synthesized, indexed reference of accurate, standardized COVID-19 information fr...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs ... gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be used mainly by health care workers at the primary health care level, but health workers at more complex and specialized levels may also find it useful.
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs ... gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be used mainly by health care workers at the primary health care level, but health workers at more complex and specialized levels may also find it useful.
